Peter J Wilkinson sold $348k of LH
SVP, Chief Accounting Officer at LABCORP HOLDINGS INC.. 1,413 shares at an average of $246.10, traded Feb 18, 2025, filed Feb 20, 2025.
Score components
- +15RoleOfficer
- +15Trade size$348k at market
- +10Share of holdings soldSold 41% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001127602-25-005895, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 1, 2022 | GGift Common Stock | -351 | $0.00 | $0 | 1,993 | Feb 20, 2025 |
| Feb 18, 2025 | MOption exercise Common Stock | +1,413 | $163.63 | $231k | 3,406 | Feb 20, 2025 |
| Feb 18, 2025 | SOpen-market sale Common Stock | -1,413 | $246.10 | $348k | 1,993 | Feb 20, 2025 |
| Feb 18, 2025 | MOption exercise Non-qualified Stock Optionsderivative | -1,413 | $0.00 | $0 | 0 | Feb 20, 2025 |
Related signals
Other insiders at LABCORP HOLDINGS INC. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 38Weak | sell 210b5-1 | LH LABCORP HOLDINGS INC. | Mark S Schroeder EVP, Pres Diagnostics & COO | $610k | 2,635 | |
| 20Weak | sell 210b5-1 | LH LABCORP HOLDINGS INC. | Amy B. Summy EVP, Chief Marketing Officer | $176k | 758 | |
| 41Moderate | sell 4 | LH LABCORP HOLDINGS INC. | Kerrii B Anderson director | $128k | 500 | |
| 45Moderate | sell 510b5-1 | LH LABCORP HOLDINGS INC. | Mark S Schroeder EVP, Pres Diagnostics & COO | $1.3M | 5,339 | |
| 55Moderate | sell 6 | LH LABCORP HOLDINGS INC. | Sandra D van der Vaart EVP, Chief Legal Officer | $330k | 1,314 | |
| 17Weak | sell 610b5-1 | LH LABCORP HOLDINGS INC. | Amy B. Summy EVP, Chief Marketing Officer | $57k | 226 | |
| 30Weak | sell 410b5-1 | LH LABCORP HOLDINGS INC. | Adam H Schechter President & CEO | $1.5M | 6,121 | |
| 8Weak | sell10b5-1 | LH LABCORP HOLDINGS INC. | Kerrii B Anderson director | $235k | 1,000 | |
| 50Moderate | sell 4 | LH LABCORP HOLDINGS INC. | Glenn A Eisenberg Executive Vice President | $2.8M | 11,711 | |
| 48Moderate | sell 4 | LH LABCORP HOLDINGS INC. | Dwight Gary Gilliland director | $241k | 1,000 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.